| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 7e-07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.094 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.09 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.081 | 0.1 |